Epigenetic Inactivation of SFRP Genes and TP53 Alteration Act Jointly as Markers of Invasive Bladder Cancer
- 15 August 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 65 (16) , 7081-7085
Abstract
In the United States each year, almost 13,000 deaths are attributable to bladder cancer, with the majority of these deaths related to higher stage, muscle-invasive solid tumors. Epigenetic silencing of the secreted frizzled receptor proteins (SFRP), antagonists of the WNT pathway, leads to constitutive WNT signaling, altering cell morphology and motility. Identifying alterations in this pathway in bladder cancer may prove useful for defining the invasive phenotype and provide targets for guiding therapy. Using a population-based study of bladder cancer (n = 355), we examined epigenetic alterations, specifically gene promoter hypermethylation, of four SFRP genes in addition to immunohistochemical staining of TP53, which has been previously shown to be a predictor of invasive disease. We observed a significant linear trend (P < 0.0004) in the magnitude of the risk of invasive disease with the number of SFRP genes methylated. Both TP53 alteration and SFRP gene methylation showed significant independent associations with invasive bladder cancer. Strikingly, in examining the joint effect of these alterations, we observed a >30-fold risk of invasive disease for patients with both altered SFRP gene methylation and intense TP53 staining (odds ratio, 32.1; P < 10−13). Overall patient survival was significantly poorer in patients with any SFRP genes methylated (P < 0.0003) and in proportional hazards modeling, patients with methylation of any SFRP gene had significantly poorer overall survival (hazard ratio, 1.78; P < 0.02) controlled for TP53 staining intensity and other survival-associated factors. Classifying tumors based on SFRP methylation status and TP53 protein staining intensity may be a clinically powerful predictor of invasive, deadly disease.Keywords
This publication has 19 references indexed in Scilit:
- TP53 alterations and patterns of carcinogen exposure in a U.S. population‐based study of bladder cancerInternational Journal of Cancer, 2005
- Detection of Methylated Apoptosis-Associated Genes in Urine Sediments of Bladder Cancer PatientsClinical Cancer Research, 2004
- Gene Expression in the Urinary BladderCancer Research, 2004
- Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancerLaboratory Investigation, 2004
- Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancerNature Genetics, 2004
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Can p53 staining be used to identify patients with aggressive superficial bladder cancer?The Journal of Pathology, 2003
- Early Cystectomy for Clinical Stage T1 Transitional Cell Carcinoma of the BladderJournal of Urology, 1998
- Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population.Environmental Health Perspectives, 1998
- Should pT1 Transitional Cell Cancers of the Bladder still be Classified as Superficial?British Journal of Urology, 1988